Pharmaceutical Information |
Drug Name |
Nelfinavir mesylate |
Drug ID |
BADD_D01550 |
Description |
Nelfinavir is a potent HIV-1 protease inhibitor. It is used in combination with other antiviral drugs in the treatment of HIV in both adults and children. Nelfinavir inhibits the HIV viral proteinase enzyme which prevents cleavage of the gag-pol polyprotein, resulting in noninfectious, immature viral particles. |
Indications and Usage |
Used in combination with other antiviral drugs in the treatment of HIV in both adults and children. |
Marketing Status |
approved |
ATC Code |
J05AE04 |
DrugBank ID |
DB00220
|
KEGG ID |
D00899
|
MeSH ID |
D019888
|
PubChem ID |
64142
|
TTD Drug ID |
Not Available
|
NDC Product Code |
63010-010; 63010-027 |
UNII |
98D603VP8V
|
Synonyms |
Nelfinavir | Viracept | AG 1343 | AG1343 | AG-1343 | Nelfinavir Mesylate | Mesylate, Nelfinavir | Nelfinavir Monomethane Sulfonate | Monomethane Sulfonate, Nelfinavir | Sulfonate, Nelfinavir Monomethane |
|
Chemical Information |
Molecular Formula |
C33H49N3O7S2 |
CAS Registry Number |
159989-65-8 |
SMILES |
CC1=C(C=CC=C1O)C(=O)NC(CSC2=CC=CC=C2)C(CN3CC4CCCCC4CC3C(=O)NC(C)(C)C)O.CS(=O)(=O
)O |
Chemical Structure |
|
|
ADRs Induced by Drug |
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|